|
US4395423A
(en)
|
1978-10-10 |
1983-07-26 |
Sterling Drug Inc. |
Polycyclic cyanoketones
|
|
US5064823A
(en)
|
1988-08-24 |
1991-11-12 |
Research Triangle Institute |
Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
|
|
DE19817262A1
(de)
|
1998-04-18 |
1999-10-21 |
Bayer Ag |
Neue 2-heterocyclisch substituierte Dihydropyrimidine
|
|
US6326507B1
(en)
|
1998-06-19 |
2001-12-04 |
Trustees Of Dartmouth College |
Therapeutic compounds and methods of use
|
|
US6369101B1
(en)
|
1999-02-26 |
2002-04-09 |
Regents Of The University Of Minnesota |
Therapeutic method to treat herpes virus infection
|
|
PT1178952E
(pt)
|
1999-05-14 |
2007-12-04 |
Univ California |
Novos moduladores da interleucina-1 e do factor alfa de necrose tumoral, síntese dos referidos moduladores e métodos de utilização dos referidos moduladores
|
|
US6649654B1
(en)
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
|
WO2002003996A1
(en)
|
2000-07-12 |
2002-01-17 |
RAJKUMAR, Sujatha |
Use of dammarane-type tritepenoid saporins
|
|
US6689767B2
(en)
|
2000-09-29 |
2004-02-10 |
Regents Of The University Of Minnesota |
Triterpenes having antibacterial activity
|
|
US6951847B2
(en)
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
|
JP2004509972A
(ja)
|
2000-09-29 |
2004-04-02 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
酵母に対する殺真菌活性を有するトリテルペン
|
|
US7435755B2
(en)
|
2000-11-28 |
2008-10-14 |
The Trustees Of Dartmouth College |
CDDO-compounds and combination therapies thereof
|
|
WO2002047611A2
(en)
|
2000-11-28 |
2002-06-20 |
Board Of Regents, The University Of Texas System |
Cddo-compounds and combination therapies thereof
|
|
DK1465615T3
(da)
|
2002-01-15 |
2012-11-12 |
Dartmouth College |
Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
|
|
DE60325329D1
(de)
|
2002-01-18 |
2009-01-29 |
Univ Minnesota |
Quaternäre terpensalze als biologisch aktive tenside
|
|
EP1507541A4
(en)
|
2002-05-13 |
2009-06-03 |
Dartmouth College |
HEMMER AND APPLICATION METHOD THEREFOR
|
|
AU2005282437B2
(en)
|
2004-09-07 |
2013-01-10 |
Pacific Arrow Limited |
Anti-tumor compounds with angeloyl groups
|
|
US20050208151A1
(en)
|
2003-10-30 |
2005-09-22 |
Entelos, Inc. |
Treatment of rheumatoid arthritis with FLIP antagonists
|
|
WO2005046732A2
(en)
|
2003-11-04 |
2005-05-26 |
THE UNITED SATES OF AMERICA as represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES, NIH |
Methods and compositions for the inhibition of hiv-1 replication
|
|
US20060258752A1
(en)
|
2004-02-12 |
2006-11-16 |
Vander Jagt David L |
Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitors
|
|
AU2006265113A1
(en)
|
2005-07-01 |
2007-01-11 |
The Johns Hopkins University |
Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
|
|
US20070232577A1
(en)
|
2006-03-23 |
2007-10-04 |
Advanced Life Sciences, Inc. |
Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin
|
|
WO2007127791A2
(en)
|
2006-04-25 |
2007-11-08 |
The Administrators Of The Tulane Educational Fund |
New pharmacological method for treatment of neuropathic pain
|
|
WO2008000070A1
(en)
|
2006-06-27 |
2008-01-03 |
Wellington Laboratories Inc. |
Glycyrrhetinic acid derivatives
|
|
WO2008016095A1
(en)
|
2006-08-02 |
2008-02-07 |
Santen Pharmaceutical Co., Ltd. |
PREVENTIVE OR REMEDY FOR KERATOCONJUNCTIVAL DISORDERS CONTAINING Nrf2 ACTIVATOR AS THE ACTIVE INGREDIENT
|
|
EP2094651A1
(en)
|
2006-11-17 |
2009-09-02 |
Trustees Of Dartmouth College |
Synthesis and biological activities of new tricyclic-bis-enones (tbes)
|
|
WO2008064132A2
(en)
|
2006-11-17 |
2008-05-29 |
Trustees Of Dartmouth College |
Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
|
|
WO2012106190A1
(en)
|
2011-01-31 |
2012-08-09 |
Bristol-Myers Squibb Company |
C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
|
|
EP2653873B8
(en)
|
2007-02-08 |
2022-08-24 |
Biogen MA Inc. |
Compositions and uses for treating Multiple Sclerosis
|
|
JP2008247898A
(ja)
|
2007-03-08 |
2008-10-16 |
Santen Pharmaceut Co Ltd |
トリテルペノイドを有効成分として含有する酸化ストレスが関連する眼疾患の予防又は治療剤
|
|
WO2008136838A1
(en)
|
2007-05-04 |
2008-11-13 |
Trustees Of Dartmouth College |
Novel amide derivatives of cddo and methods of use thereof
|
|
US8088824B2
(en)
|
2007-08-15 |
2012-01-03 |
Reata Pharmaceuticals Inc. |
Forms of CDDO methyl ester
|
|
US20090048205A1
(en)
|
2007-08-15 |
2009-02-19 |
Colin Meyer |
Combination therapy with synthetic triterpenoids and gemcitabine
|
|
US9012439B2
(en)
|
2007-10-29 |
2015-04-21 |
University Of Rochester |
Use of electrophilic compounds for inducing platelet production or maintaining platelet function
|
|
ME03529B
(me)
|
2008-01-11 |
2020-04-20 |
Reata Pharmaceuticals Inc |
Sintetički triterpenoidi i metode njihove upotrebe u tretmanu bolesti
|
|
HUE033288T2
(en)
|
2008-04-18 |
2017-11-28 |
Reata Pharmaceuticals Inc |
Antioxidant inflammation modulators: C-17 homologated oleic acid derivatives
|
|
TW201006474A
(en)
|
2008-04-18 |
2010-02-16 |
Reata Pharmaceuticals Inc |
Natural products including an anti-flammatory pharmacore and methods of use
|
|
US8071632B2
(en)
|
2008-04-18 |
2011-12-06 |
Reata Pharmaceuticals, Inc. |
Antioxidant inflammation modulators: novel derivatives of oleanolic acid
|
|
EP2279197B1
(en)
|
2008-04-18 |
2014-11-05 |
Reata Pharmaceuticals, Inc. |
Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
|
|
RS58392B1
(sr)
|
2008-04-18 |
2019-04-30 |
Reata Pharmaceuticals Inc |
Antioksidantni modulatori inflamacije: derivati oleanoličke kiseline sa amino i drugim modifikacijama na c-17
|
|
ES2449396T3
(es)
|
2008-07-22 |
2014-03-19 |
Trustees Of Dartmouth College |
Cianoenonas monocíclicas y métodos de uso de las mismas
|
|
WO2010053817A1
(en)
|
2008-11-04 |
2010-05-14 |
Trustees Of Dartmouth College |
Betulinic acid derivatives and methods of use thereof
|
|
SG173601A1
(en)
|
2009-02-13 |
2011-09-29 |
Reata Pharmaceuticals Inc |
Delayed release, oral dosage compositions that contain amorphous cddo-me
|
|
AU2011240690C1
(en)
|
2010-04-12 |
2014-11-06 |
Reata Pharmaceuticals Holdings, LLC |
Method of treating obesity using antioxidant inflammation modulators
|
|
US8618125B2
(en)
|
2011-01-14 |
2013-12-31 |
Heptiva LLC |
Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
|
|
EA026847B1
(ru)
*
|
2011-03-11 |
2017-05-31 |
Рита Фармасьютикалз, Инк. |
C4-монометилтритерпеноидные производные и способы их применения
|
|
EP2841445B1
(en)
|
2012-04-27 |
2017-06-14 |
Reata Pharmaceuticals, Inc. |
2.2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
|
|
WO2013169740A2
(en)
|
2012-05-08 |
2013-11-14 |
Trustees Of Dartmouth College |
Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression
|
|
US8921419B2
(en)
|
2012-05-08 |
2014-12-30 |
Trustees Of Dartmouth College |
Triterpenoids and compositions containing the same
|
|
US9556222B2
(en)
|
2012-06-15 |
2017-01-31 |
Reata Pharmaceuticals, Inc. |
A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
|
|
CN103665087A
(zh)
|
2012-09-03 |
2014-03-26 |
上海源力生物技术有限公司 |
一种萜类化合物及其在医药上的应用
|
|
MX2015003021A
(es)
|
2012-09-10 |
2015-11-09 |
Abbvie Inc |
Derivados de acido glicirretinico y metodos de uso de los mismos.
|
|
US9512094B2
(en)
|
2012-09-10 |
2016-12-06 |
Reata Pharmaceuticals, Inc. |
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
|
|
TWI630212B
(zh)
|
2012-09-10 |
2018-07-21 |
瑞塔醫藥有限責任公司 |
丁香油素（ｏｌｅａｎｏｌｉｃ ａｃｉｄ）之ｃ１７－烷二基與烯二基衍生物及其使用方法
|
|
US9278912B2
(en)
|
2012-09-10 |
2016-03-08 |
Reata Pharmaceuticals, Inc. |
C13-hydroxy derivatives of oleanolic acid and methods of use thereof
|
|
LT2892911T
(lt)
*
|
2012-09-10 |
2017-11-10 |
Reata Pharmaceuticals, Inc. |
Oleanolinės rūgšties c17 heteroarilo dariniai ir jų panaudojimo būdas
|
|
TWI649330B
(zh)
|
2013-04-24 |
2019-02-01 |
艾伯維有限公司 |
甲基巴多索龍之２，２－二氟丙醯胺衍生物、其多晶形及其使用方法
|
|
IL285832B2
(en)
|
2013-08-23 |
2024-01-01 |
Reata Pharmaceuticals Inc |
Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
|
|
US9896475B2
(en)
|
2014-08-26 |
2018-02-20 |
Trustees Of Dartmouth College |
Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole
|
|
BR112018005861B1
(pt)
|
2015-09-23 |
2022-11-22 |
Reata Pharmaceuticals, Inc |
Compostos derivados de ácido oleanólico modificado com c4 para a inibição de il-17, composição farmacêutica e usos terapêuticos dos ditos compostos
|
|
BR112019009256A2
(pt)
|
2016-11-08 |
2019-07-16 |
Reata Pharmaceuticals, Inc. |
métodos para tratar síndrome de alport usando bardoxolona metil ou análogos do mesmo
|
|
CN120248001A
(zh)
|
2019-07-19 |
2025-07-04 |
里亚塔医药公司 |
C17极性的-取代的杂芳族合成三萜类化合物及其使用方法
|